Laura A. Linynsky

Board Director

Director

Mednax, Inc.Pediatrix Medical Group, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 1 saleDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (2 ops.)

€258k

Latest filing published 14 Sept 2026 for Pediatrix Medical Group, Inc., €138k.

Filing timeline

BuySale

Laura A. Linynsky

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Laura A. Linynsky: trading record in brief

Laura A. Linynsky, listed as board member, appears in our data through filings on Pediatrix Medical Group, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 12 May 2022 to 10 September 2026, the count stands at 8 filings.

Sales make up the whole of the open-market record (2 sales, €258k). Outside the open market, there are 5 share grants.

The latest filing, published on 14 September 2026, reports a transaction of €138k in Pediatrix Medical Group, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.